Complement as regulatory and effector pathway in human diseases / V. Michael Holers -- The regulation of C1 activation and its role in disease / C. Erik Hack -- Inhibition of complement serine proteases as a therapeutic strategy / Sthanam V.L. Narayana, Y. Sudhakara Babu, and John E. Volanakis -- Complement inhibitors targeting C3, C4, and C5 / Arvind Sahu, Dimitrios Morikis, and John D. Lambris -- Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammtion / Rick A. Wetsel, Jens Kildsgaard, and David L. Haviland -- Modulation of disease using recombinant human endogenous complement inhibitors / Richard J. Quigg -- Roles of integrins CR3 and CR4 in disease and therapeutic strategies / Yu Xia and Gordon D. Ross -- Inhibition of complement in the membrane attack pathway / B. Paul Morgan -- Evaluation of complement inhibitors / Patricia C. Giclas -- Use of animal models to define complement functions / Peter A. Ward ... [et al.].
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.